The influence of open-label placebos on cognitive performance
- Conditions
- Healthy volunteers
- Registration Number
- DRKS00019203
- Lead Sponsor
- niversitätsklinik Essen AöR Klinik für Neurologie
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 88
Volunteers, informed consent to study participation
1) Severe medical conditions (in particular, diagnosed psychiatric comorbidities);
2) Dyschromatopsia;
3) Harmful substance abuse (including alcohol, cannabinoids, cocaine, amphetamines) in the last 4 weeks prior to inclusion or persistence;
4) alcohol consumption on the day prior to T0 or T1;
5) Known allergy or intolerance to any of the ingredients of the placebo;
6) Parallel participation in a study using investigational medicinal products;
7) pregnancy, breastfeading
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method